---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-046872"
form_type: "8-K"
ticker: "DTIL"
cik: "0001357874"
company_name: "PRECISION BIOSCIENCES INC"
filed_at: "2023-09-07T23:59:59+00:00"
generated_at: "2026-06-10T22:39:36.409045+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Precision BioSciences Controller resigns; CFO Kelly named principal accounting officer

## Summary
- Shane Barton resigned as VP and Corporate Controller, effective Sept 15, 2023.
- CFO Alex Kelly appointed as principal accounting officer effective Sept 15, 2023.
- Senior Director Mei Burris to assume responsibilities previously held by Barton.
- Mei Burris is a CPA with prior roles at Heat Biologics and Cempra Pharmaceuticals.

## SEC filing metadata
- accession: 0000950170-23-046872
- form_type: 8-K
- ticker: DTIL
- cik: 0001357874
- company_name: PRECISION BIOSCIENCES INC
- filed_at: 2023-09-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357874/000095017023046872/0000950170-23-046872-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357874/000095017023046872/dtil-20230831.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-046872
- JSON: https://secwatch.observer/filing/0000950170-23-046872.json
- Plain text: https://secwatch.observer/filing/0000950170-23-046872.txt

## Key facts
- Executive change
  Shane Barton resigned as Vice President and Corporate Controller at PRECISION BIOSCIENCES INC.
  - Action: resigned
  - Role: Vice President and Corporate Controller
  source text: On August 31, 2023, Shane Barton notified Precision BioSciences, Inc. (the “Company”) of his resignation as the Company’s Vice President and Corporate Controller, effective September 15, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357874/000095017023046872/0000950170-23-046872-index.htm
- Executive change
  Alex Kelly changed role as Chief Financial Officer and Principal Accounting Officer at PRECISION BIOSCIENCES INC.
  - Action: designated
  - Role: Chief Financial Officer and Principal Accounting Officer
  source text: On September 6, 2023, the Company’s Board of Directors designated Alex Kelly, the Company’s Chief Financial Officer and principal financial officer, to also serve as the Company’s principal accounting officer effective upon Mr. Barton’s departure.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357874/000095017023046872/0000950170-23-046872-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.